Theranexus

Developing drug combinations that consist of one compound that targets neurons and another that modulates the activity of astrocytes.

Launch date

Jan 2013

Employees

Market cap

Enterprise valuation

€3m (Public information from Sep 2024)

Company register number 791889777

Lyon Auvergne-Rhône-Alpes (HQ)

https://www.theranexus.com/fr/

https://twitter.com/theranexus https://www.linkedin.com/company/theranexus/

Authorizing premium user...